Product: KHDRBS1 Antibody
Catalog: DF7853
Description: Rabbit polyclonal antibody to KHDRBS1
Application: WB IHC
Reactivity: Human, Mouse
Prediction: Pig, Bovine, Horse, Sheep, Rabbit, Dog, Chicken
Mol.Wt.: 48 kDa; 48kD(Calculated).
Uniprot: Q07666
RRID: AB_2841288

View similar products>>

   Size Price Inventory
 100ul $280 In stock
 200ul $350 In stock

Lead Time: Same day delivery

For pricing and ordering contact:
Local distributors

Product Info

Source:
Rabbit
Application:
WB 1:1000-3000, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

Reactivity:
Human,Mouse
Prediction:
Pig(100%), Bovine(100%), Horse(100%), Sheep(100%), Rabbit(100%), Dog(100%), Chicken(100%)
Clonality:
Polyclonal
Specificity:
KHDRBS1 Antibody detects endogenous levels of total KHDRBS1.
RRID:
AB_2841288
Cite Format: Affinity Biosciences Cat# DF7853, RRID:AB_2841288.
Conjugate:
Unconjugated.
Purification:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
Storage:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
Alias:

Fold/Unfold

FLJ34027; GAP associated tyrosine phosphoprotein p62; GAP-associated tyrosine phosphoprotein p62; KH domain containing RNA binding signal transduction associated 1; KH domain-containing; KHDR1_HUMAN; Khdrbs1; p21 Ras GTPase activating protein associated p62; p21 Ras GTPase-activating protein-associated p62; p62; p68; RNA-binding; Sam68; signal transduction-associated protein 1; Src associated in mitosis 68 kDa protein; Src-associated in mitosis 68 kDa protein;

Immunogens

Immunogen:
Uniprot:
Gene(ID):
Expression:
Q07666 KHDR1_HUMAN:

Ubiquitously expressed in all tissue examined. Isoform 1 is expressed at lower levels in brain, skeletal muscle, and liver whereas isoform 3 is intensified in skeletal muscle and in liver.

Sequence:
MQRRDDPAARMSRSSGRSGSMDPSGAHPSVRQTPSRQPPLPHRSRGGGGGSRGGARASPATQPPPLLPPSATGPDATVGGPAPTPLLPPSATASVKMEPENKYLPELMAEKDSLDPSFTHAMQLLTAEIEKIQKGDSKKDDEENYLDLFSHKNMKLKERVLIPVKQYPKFNFVGKILGPQGNTIKRLQEETGAKISVLGKGSMRDKAKEEELRKGGDPKYAHLNMDLHVFIEVFGPPCEAYALMAHAMEEVKKFLVPDMMDDICQEQFLELSYLNGVPEPSRGRGVPVRGRGAAPPPPPVPRGRGVGPPRGALVRGTPVRGAITRGATVTRGVPPPPTVRGAPAPRARTAGIQRIPLPPPPAPETYEEYGYDDTYAEQSYEGYEGYYSQSQGDSEYYDYGHGEVQDSYEAYGQDDWNGTRPSLKAPPARPVKGAYREHPYGRY

Predictions

Predictions:

Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.

Species
Results
Score
Pig
100
Horse
100
Bovine
100
Sheep
100
Dog
100
Chicken
100
Rabbit
100
Xenopus
0
Zebrafish
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

PTMs - Q07666 As Substrate

Site PTM Type Enzyme
R10 Methylation
S12 Phosphorylation
S14 Phosphorylation
S15 Phosphorylation
R17 Methylation
S18 Phosphorylation
S20 Phosphorylation
S24 Phosphorylation
S29 Phosphorylation
T33 Phosphorylation
S35 Phosphorylation
R36 Methylation
R43 Methylation
S44 Phosphorylation
R45 Methylation
R52 Methylation
S58 Phosphorylation P28482 (MAPK1) , Q16539 (MAPK14)
T61 Phosphorylation
T72 Phosphorylation P28482 (MAPK1)
T77 Phosphorylation
T84 Phosphorylation P28482 (MAPK1) , Q16539 (MAPK14)
K96 Acetylation
K96 Sumoylation
K102 Sumoylation
Y103 Phosphorylation
K111 Ubiquitination
S113 Phosphorylation
T119 Phosphorylation
K131 Ubiquitination
S137 Phosphorylation
K139 Ubiquitination
Y145 Phosphorylation
S150 Phosphorylation
K152 Ubiquitination
K165 Acetylation
K165 Ubiquitination
K169 Acetylation
K169 Ubiquitination
K175 Acetylation
K175 Methylation
K175 Sumoylation
K175 Ubiquitination
T183 Phosphorylation
K185 Sumoylation
K185 Ubiquitination
K194 Methylation
K194 Ubiquitination
S196 Phosphorylation
K200 Methylation
K200 Ubiquitination
S202 Phosphorylation
K208 Acetylation
R213 Methylation
K252 Acetylation
K253 Acetylation
R282 Methylation
R284 Methylation
R289 Methylation
R291 Methylation
R302 Methylation
R304 Methylation
R310 Methylation
R315 Methylation
T317 Phosphorylation P06493 (CDK1)
R320 Methylation
R325 Methylation
R331 Methylation
R340 Methylation
R346 Methylation
R348 Methylation
T365 Phosphorylation
Y366 Phosphorylation
Y369 Phosphorylation
Y371 Phosphorylation
T374 Phosphorylation
Y375 Phosphorylation
Y380 Phosphorylation
Y387 Phosphorylation
S388 Phosphorylation
S390 Phosphorylation
Y396 Phosphorylation
Y397 Phosphorylation
Y408 Phosphorylation
Y411 Phosphorylation
K424 Ubiquitination
K432 Methylation
K432 Ubiquitination
Y435 Phosphorylation Q13882 (PTK6)
Y440 Phosphorylation Q13882 (PTK6)
R442 Methylation
Y443 Phosphorylation Q13882 (PTK6)

Research Backgrounds

Function:

Recruited and tyrosine phosphorylated by several receptor systems, for example the T-cell, leptin and insulin receptors. Once phosphorylated, functions as an adapter protein in signal transduction cascades by binding to SH2 and SH3 domain-containing proteins. Role in G2-M progression in the cell cycle. Represses CBP-dependent transcriptional activation apparently by competing with other nuclear factors for binding to CBP. Also acts as a putative regulator of mRNA stability and/or translation rates and mediates mRNA nuclear export. Positively regulates the association of constitutive transport element (CTE)-containing mRNA with large polyribosomes and translation initiation. According to some authors, is not involved in the nucleocytoplasmic export of unspliced (CTE)-containing RNA species according to. RNA-binding protein that plays a role in the regulation of alternative splicing and influences mRNA splice site selection and exon inclusion. Binds to RNA containing 5'-[AU]UAA-3' as a bipartite motif spaced by more than 15 nucleotides. Binds poly(A). Can regulate CD44 alternative splicing in a Ras pathway-dependent manner (By similarity). In cooperation with HNRNPA1 modulates alternative splicing of BCL2L1 by promoting splicing toward isoform Bcl-X(S), and of SMN1. Can regulate alternative splicing of NRXN1 and NRXN3 in the laminin G-like domain 6 containing the evolutionary conserved neurexin alternative spliced segment 4 (AS4) involved in neurexin selective targeting to postsynaptic partners. In a neuronal activity-dependent manner cooperates synergistically with KHDRBS2/SLIM-1 in regulation of NRXN1 exon skipping at AS4. The cooperation with KHDRBS2/SLIM-1 is antagonistic for regulation of NXRN3 alternative splicing at AS4 (By similarity).

Isoform 3, which is expressed in growth-arrested cells only, inhibits S phase.

PTMs:

Tyrosine phosphorylated by several non-receptor tyrosine kinases including LCK, FYN and JAK3. Also tyrosine phosphorylated by the non-receptor tyrosine kinase SRMS in an EGF-dependent manner. Negatively correlates with ability to bind RNA but required for many interactions with proteins. Phosphorylation by PTK6 negatively regulates its RNA binding ability. Phosphorylation by PTK6 at Tyr-440 dictates the nuclear localization of KHDRBS1. Phosphorylation at Tyr-387 disrupts interaction with APC. Phosphorylation at tyrosine residues by FYN inverts activity on modulation of BCL2L1 alternative splicing.

Acetylated. Positively correlates with ability to bind RNA.

Arginine methylation is required for nuclear localization. Also can affect interaction with other proteins. Inhibits interaction with Src-like SH3 domains, but not interaction with WW domains of WBP4/FBP21 AND FNBP4/FBP30.

Subcellular Location:

Nucleus. Cytoplasm. Membrane.
Note: Predominantly located in the nucleus but also located partially in the cytoplasm.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
Tissue Specificity:

Ubiquitously expressed in all tissue examined. Isoform 1 is expressed at lower levels in brain, skeletal muscle, and liver whereas isoform 3 is intensified in skeletal muscle and in liver.

Subunit Structure:

Self-associates to form homooligomers when bound to RNA, oligomerization appears to be limited when binding to proteins; dimerization increases RNA affinity. Interacts with KHDRBS3/SLIM-2. Interacts with KHDRBS2/SLIM-1; heterooligomer formation of KHDRBS family proteins may modulate RNA substrate specificity (By similarity). Interacts with RASA1, LCK, FYN, PTPN6, PLCG1, GRB2, CBL, JAK3, PIK3R, STAT3, APC, HNRNPA1. Interacts with PTK6 (via SH3 and SH2 domains). Forms a complex with ILF2, ILF3, YLPM1, RBMX, NCOA5 and PPP1CA. Does not interact with TPR. Interacts with RBMY1A1, PRMT1 (By similarity). Binds WBP4/FBP21 (via WW domains), FNBP4/FBP30 (via WW domains). Interacts (via Arg/Gly-rich-flanked Pro-rich regions) with FYN (via the SH3 domain) (By similarity). Interacts with the non-receptor tyrosine kinase SRMS; the interaction leads to phosphorylation of KHDRBS1. Interacts with ZBTB7A; negatively regulates KHDRBS1 splicing activity toward BCL2L1.

Family&Domains:

The KH domain is required for binding to RNA.

The Pro-rich domains are flanked by Arg/Gly-rich motifs which can be asymmetric dimethylated on arginine residues to give the DMA/Gly-rich regions. Selective methylation on these motifs can modulate protein-protein interactions (By similarity).

Belongs to the KHDRBS family.

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.